immunology of infectious and parasitic diseases - XXXVII Congress ...
immunology of infectious and parasitic diseases - XXXVII Congress ...
immunology of infectious and parasitic diseases - XXXVII Congress ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
PURINERGIC RECEPTOR P2Y12 ACTIVATION IN SCHISTOSOMAL HOST<br />
RESPONSE<br />
VALDIRENE S. MUNIZ 1 ; RENATA B. REIS 1 ; HILTON A. MATA-SANTOS 2 ;<br />
ALEXANDRE S. PYRRHO 2 ; PETER F. WELLER 3 ; RODRIGO T. FIGUEIREDO 4<br />
AND JOSIANE S. NEVES 1<br />
1 Institute <strong>of</strong> Biomedical Sciences, 2 Faculty <strong>of</strong> Pharmacy, Federal University <strong>of</strong> Rio de<br />
Janeiro, Rio de Janeiro, RJ, Brazil, 3 Division <strong>of</strong> Allergy <strong>and</strong> Inflammation, Harvard<br />
Medical School, Beth Israel Deaconess Medical Center, Boston, MA, USA, 4 Institute<br />
<strong>of</strong> Biomedical Sciences/Unit <strong>of</strong> Xerem.<br />
Introduction: Identification <strong>of</strong> new target molecules through which eosinophils<br />
activate <strong>and</strong> secrete their stored proteins may be highly significant for our<br />
underst<strong>and</strong>ing about the pathophysiology <strong>of</strong> host immune responses to parasites<br />
<strong>and</strong> allergic inflammation, as well as reveal new therapeutic targets for the control <strong>of</strong><br />
the eosinophilic disorders. We have recently reported the expression <strong>of</strong> the<br />
purinergic P2Y12 receptor (P2Y12R) in human eosinophils (JACI 125:477-482,<br />
2010), however, their involvement in eosinophilic inflammatory conditions in vivo,<br />
particularly in host response to parasites is still unknown.<br />
In this work we investigated the role <strong>of</strong> the purinergic P2Y12R in the eosinophilic<br />
inflammatory response induced by Shistosoma mansoni (S. mansoni) infection.<br />
Methods <strong>and</strong> Results: C57Bl/6 mice were infected with 50 cercariae <strong>of</strong> the BH<br />
strain <strong>of</strong> S. mansoni by the cutaneous route (protocol licence CEUA/UFRJ<br />
DFBCICB043). The animals were treated with a P2Y12R antagonist, clopidogrel<br />
(500μg/mL), via the drinking water three days before <strong>and</strong> throughout the infection<br />
period (55 days). Histopathological <strong>and</strong> biochemical analyses were performed in the<br />
liver to evaluate the areas <strong>of</strong> inflammatory granulomatous infiltrate <strong>and</strong> collagen<br />
deposition. The P2Y12R blockage reduced the hepatic inflammatory infiltrate around<br />
the granuloma – not treated: 5.47 ± 1.8 versus treated 4.2 ± 1.6 (x10 4<br />
μm 2 /granuloma), means ± EPM, N=5 - as well as liver collagen deposition – not<br />
treated: 880 ± 7 versus treated 690 ± 6 (μg hydroxyproline/g liver), means ± EPM,<br />
N=5 - without altering the parasite oviposition. Furthermore, the P2Y12R inhibition<br />
promoted blood eosinophilia (2-fold increase, N=5), whereas decreased the<br />
eosinophil count in the bone marrow (60% reduction, N=5) after blood smears <strong>and</strong><br />
cytospin analyses, respectively.<br />
Conclusion: Our results indicate an important role <strong>of</strong> the P2Y12R in the modulation<br />
<strong>of</strong> the host inflammatory response caused by S. mansoni infection. Our studies<br />
might enhance underst<strong>and</strong>ing <strong>of</strong> the importance <strong>of</strong> eosinophil activation <strong>and</strong><br />
migration to parasite infected sites.<br />
Financial support : FAPERJ <strong>and</strong> CNPq.